Brought to you by Global Information, Inc.
Pharmaceuticals and Healthcare Report - Country Reports
- Published by: Business Monitor International
- Published: December, 2011
- Format : PDF /
- Delivery: E-Mail within 1-2 business days
- Product ID: 222411
Description
Coverage
BMI's Pharmaceuticals & Healthcare service provides unparalleled analysis and forecasts of market expenditure covering all therapeutic areas, disease prevalence, regulatory and reimbursement policies, and company-by-company activity globally. BMI's analysts constantly revise and update almost 80 reports and maintain industry forecasts for virtually the entire global pharmaceuticals market.
Methodology
The service covers all key developments within the following areas: generic drugs, over-the-counter (OTC) medicines, patented drugs, research and development, regulations, biotechnology, medical devices, pricing and reimbursement, imports and exports, supply chain, and epidemiology. At its heart is BMI's proprietary 10-year Pharmaceutical Expenditure Forecast Model, which incorporates historic trends, macroeconomic variables, epidemiological forecasts and analyst input.
A second unique component of the data service is BMI's country-comparative risk-reward Business Environment Rating. This tool facilitates the critical evaluation of opportunities and operational risk in established, emerging and frontier markets, enabling clients to identify and evaluate global industry investment opportunities.
Table of Contents
CHECK the list of Countries
EXAMPLE Country Report
The following is the table of contents of one selected report in the series and serves as an example of the typical items covered in each country report. Certain sections in each report may be removed or altered based on the availability and relevance of data.
* This series will be available by country.
* The price and the publishing date may vary depending on the country. Please contact us for details.
New Zealand Pharmaceuticals and Healthcare Report
Executive Summary
SWOT Analysis
- New Zealand Pharmaceuticals & Healthcare Industry SWOT
- New Zealand Political SWOT
- New Zealand Economic SWOT
- New Zealand Business Environment SWOT
Business Environment Ratings
- Pharmaceuticals Business Environment Ratings
- Table: Asia Pacific - Regional Pharmaceutical Business Environment Ratings, Q112
- Rewards
- Risks
New Zealand - Market Summary
Regulatory Regime
- Intellectual Property Protection
- Pricing And Reimbursement
- Table: Leading Therapeutic Groups By PHARMAC Expenditure (NZDmn)
- Table: Top 20 Medicines By Ex-Manufacturer Cost To PHARMAC In The Year Ending June 2010 (NZDmn)
- Table: Top 20 Medicines Reimbursed By PHARMAC According To Prescription Numbers In The Year Ending June 2010
- Recent Regulatory Developments
Industry Developments
- Epidemiology
- Clinical Trials Sector
- Medical Devices
Industry Forecast Scenario
- Pharmaceutical Market Forecast
- Table: New Zealand's Pharmaceutical Sales, Historical Data and Forecast, 2007-2016
- Healthcare Market Forecast
- Table: New Zealand's Healthcare, Historical Data and Forecast, 2007-2016
- Key Growth Factors - Macroeconomic Forecast
- Table: New Zealand - Economic Activity
- Prescription Drug Market Forecast
- Table: New Zealand - Pharmaceutical Prescription Drug Sales, Historical Data and Forecast, 2007-2016
- Patented Drug Market Forecast
- Table: New Zealand - Pharmaceutical Patented Drug Sales, Historical Data and Forecast, 2007-2016
- Generic Drug Market Forecast
- Table: New Zealand - Pharmaceutical Generic Drug Sales, Historical Data and Forecast, 2007-2016
- OTC Drug Market Forecast
- Table: New Zealand - Pharmaceutical OTC Medicine Sales, Historical Data and Forecast, 2007-2016
- Medical Devices Market Forecast
- Table: New Zealand - Medical Device Sales, Historical Data and Forecast, 2007-2016
- Pharmaceutical Trade Forecast
- Table: New Zealand - Pharmaceuticals, Historical Data and Forecast, 2007-2016
- Other Healthcare Data
- Key Risks To BMI's Forecast Scenario
Competitive Landscape
- Pharmaceutical Industry
- Pharmaceuticals & Healthcare Companies Listed On The New Zealand Stock Exchange (NZX)
- Company Developments
Company Profiles
- Douglas Pharmaceuticals
- New Zealand Pharmaceuticals
Glossary
BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
“Pharmaceuticals and Healthcare Report” series includes reports covering the following countries.
Related Reports
